Neurizon Therapeutics Ltd
WKN: A40STF / ISIN: AU0000357261PharmAust human and veterinary medicines
| eröffnet am: | 04.01.16 09:59 von: | new1aroundhere |
| neuester Beitrag: | 25.04.21 03:09 von: | Leahbdjva |
| Anzahl Beiträge: | 10 | |
| Leser gesamt: | 9606 | |
| davon Heute: | 3 | |
bewertet mit -1 Stern |
||
|
|
||
04.01.16 09:59
#1
new1aroundhere
PharmAust human and veterinary medicines
About Epichem & Pitney Pharmamaceuticals
In August 2013, PharmAust acquired Pitney Pharmaceuticals Ltd and raised funds to develop its product pipeline, which now includes both human and veterinary proprietary medicines to treat cancer.
As a result, PharmAust now also has two key strategic alliances with major pharmaceutical companies and products already in phase II trials. These products target substantial multi-billion dollar markets.
PharmAust specialises in the relaunch of existing marketed products for oncology applications making the whole development, regulatory and commercialisation process much faster. In addition, PharmAust ‘s other wholly owned subsidiary, Epichem Pty Ltd generates sales of around $1.7M per annum from contract sales to the pharmaceutical industry of synthetic drugs.
Epichem is also facilitating the generation of new IP by synthesizing analogues for projects within the group.
http://www.pharmaust.com/about-us.html
In August 2013, PharmAust acquired Pitney Pharmaceuticals Ltd and raised funds to develop its product pipeline, which now includes both human and veterinary proprietary medicines to treat cancer.
As a result, PharmAust now also has two key strategic alliances with major pharmaceutical companies and products already in phase II trials. These products target substantial multi-billion dollar markets.
PharmAust specialises in the relaunch of existing marketed products for oncology applications making the whole development, regulatory and commercialisation process much faster. In addition, PharmAust ‘s other wholly owned subsidiary, Epichem Pty Ltd generates sales of around $1.7M per annum from contract sales to the pharmaceutical industry of synthetic drugs.
Epichem is also facilitating the generation of new IP by synthesizing analogues for projects within the group.
http://www.pharmaust.com/about-us.html
05.01.16 08:59
#2
new1aroundhere
PharmAust Limited (ASX:PAA)
is a public company listed on the Australian Securities Exchange. The principal activities of the company are to develop its own drug discovery intellectual property, namely three platforms for the treatment of different types of cancers in humans and animals, as well as providing highly specialised medicinal and synthetic chemistry services on a contract basis to clients.
Im Gegensatz zu vielen anderen companies da draußen kann PharmAust die gesteckten Ziele zumindest auch umsetzen und nicht nur shareholder Kapital vergeuden!!!! tzzzzzz
Schaut mal im investor centre nach!!!!!!!!!!!
http://www.pharmaust.com/company-presentation.html
Im Gegensatz zu vielen anderen companies da draußen kann PharmAust die gesteckten Ziele zumindest auch umsetzen und nicht nur shareholder Kapital vergeuden!!!! tzzzzzz
Schaut mal im investor centre nach!!!!!!!!!!!
http://www.pharmaust.com/company-presentation.html
05.01.16 09:03
#3
new1aroundhere
Frankfurt startet heute mit +9,43%
ins Rennen und bislang sind noch keine trades zu verzeichnen. Sieht ganz nach upwind an!!!!!
07.01.16 08:12
#4
new1aroundhere
7th JAN closing on ASX
!! !! !! !! !! !! !! !! !! !! !! !! !! !! !! !! !! !! !! !! !!
http://www.google.com/finance?cid=680328
0.130 AUD +0,033 AUD (+34,02%)
!! !! !! !! !! !! !! !! !! !! !! !! !! !! !! !! !! !! !! !! !!
http://www.google.com/finance?cid=680328
0.130 AUD +0,033 AUD (+34,02%)
!! !! !! !! !! !! !! !! !! !! !! !! !! !! !! !! !! !! !! !! !!
07.01.16 08:32
#5
new1aroundhere
Frankfurt legt nach zum Auftakt mit +14,04%
Aktueller Kurs 0,065€
bid 0,078€
ask 0,091€
bid 0,078€
ask 0,091€
07.01.16 08:42
#6
new1aroundhere
Frankfurt +36,84%
http://www.boerse-frankfurt.de/aktie/PharmAust-Aktie
was kümmert mich mein Geschwätz von eben :D
was kümmert mich mein Geschwätz von eben :D
11.01.16 07:49
#7
new1aroundhere
Juniper Pharma appointed for phase 2 trials
http://www.asx.com.au/asx/statistics/...isplay=pdf&idsId=01702215
